KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Tax ProvisionsTax Rate
Others
Ratios

BioNTech SE (BNTX) Net Income towards Common Stockholders (2018 - 2025)

Historic Net Income towards Common Stockholders for BioNTech SE (BNTX) over the last 8 years, with Q3 2025 value amounting to $91.3 million.

  • BioNTech SE's Net Income towards Common Stockholders fell 3031.23% to $91.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$417.3 million, marking a year-over-year increase of 2857.8%. This contributed to the annual value of -$737.4 million for FY2024, which is 17367.4% down from last year.
  • Latest data reveals that BioNTech SE reported Net Income towards Common Stockholders of $91.3 million as of Q3 2025, which was down 3031.23% from -$437.6 million recorded in Q2 2025.
  • BioNTech SE's 5-year Net Income towards Common Stockholders high stood at $7.1 billion for Q1 2022, and its period low was -$865.6 million during Q2 2024.
  • Over the past 5 years, BioNTech SE's median Net Income towards Common Stockholders value was $366.4 million (recorded in 2024), while the average stood at $1.4 billion.
  • In the last 5 years, BioNTech SE's Net Income towards Common Stockholders soared by 6418573663.12% in 2022 and then plummeted by 31749.74% in 2024.
  • Over the past 5 years, BioNTech SE's Net Income towards Common Stockholders (Quarter) stood at $3622.0 in 2021, then surged by 64185736.63% to $2.3 billion in 2022, then crashed by 78.81% to $492.7 million in 2023, then dropped by 25.63% to $366.4 million in 2024, then crashed by 75.08% to $91.3 million in 2025.
  • Its Net Income towards Common Stockholders was $91.3 million in Q3 2025, compared to -$437.6 million in Q2 2025 and -$437.4 million in Q1 2025.